Alnylam Pharmaceuticals | ALNY - Ebitda

股票价格

305.54

每天变化

-8.25 -2.63%

每月一次

-7.05%

每年

21.46%

Q2 预测

299.00

金融业

USD

USD 4.97B

现金及等价物

USD 1.66B

USD 267.72M

USD 4.05B

USD 1.47B

USD 1.31B

USD 29.4M

USD 145.22M

2.23K

EPS每股收益

USD 1.25

股本和储备

USD 789.18M

USD 829.31M

债务利息支出

USD 129.34M

USD 28.68M

USD 2.48B

USD 39.15B

USD 186.42M

USD 965.32M

USD 29.4M

普通股股本

USD 132.38M

170.7

USD 161.14M

USD 1.1B

销售和管理费用

USD 285.06M

USD 82.72M

贸易债权人

USD 115.72M

应收帐款人

USD 777.57M

	Ebitda	更改		日
Acadia Pharmaceuticals	USD 35.76M		447K	2025-09
Agios Pharmaceuticals	USD -115.49M		10.3M	2025-09
Alnylam Pharmaceuticals	USD 145.22M		236.56M	2025-12
Amgen	USD 5.14B		775M	2025-12
Arrowhead Research	USD 64.2M		223.53M	2025-09
BioCryst Pharmaceuticals	USD 51.7M		30.14M	2025-09
BioMarin Pharmaceutical	USD -24.17M		18.91M	2025-12
Incyte	USD 414.5M		92.42M	2025-12
Ionis Pharmaceuticals	USD -157.12M		307.36M	2025-09
Moderna	USD -790M		582M	2025-12
Neurocrine Biosciences	USD 218.4M		28.3M	2025-12
Novartis	USD 5.84B		235M	2025-09
PTC Therapeutics	USD -70.99M		91.62M	2025-12
Regeneron Pharmaceuticals	USD 1.92B		261.9M	2025-09
Sanofi	EUR 5.66B		3.77B	2025-09
Sarepta Therapeutics	USD -168.03M		294.45M	2025-09
Takeda	JPY 448.13B		173.98B	2025-12
Tectonic Therapeutic	USD -21.18M		365K	2025-12
Ultragenyx Pharmaceutical	USD -156.79M		65.44M	2025-09
Vertex Pharmaceuticals	USD 1.44B		100.4M	2025-09
Xencor	USD -51.05M		55.28M	2025-12